The treatment of chronic strongyloidiasis with thiabendazole
- 1 January 1967
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 61 (6) , 812-816
- https://doi.org/10.1016/0035-9203(67)90040-5
Abstract
A favorable response occurred in 81.5% of 27 persons treated and followed up from 1 month to 1 year. Thiabendazole offers the advantage of a short course of treatment and its side effects, though common, are generally tolerated.This publication has 5 references indexed in Scilit:
- Thiabendazole Effectiveness In Creeping EruptionArchives of Dermatology, 1965
- ABSORPTION METABOLISM AND ELIMINATION OF THIABENDAZOLE IN FARM ANIMALS AND A METHOD FOR ITS ESTIMATION IN BIOLOGICAL MATERIALS1965
- Clinical Evaluation of a new Anthelmintic—Thiabendazole [2-(4′-Thiazolyl)-Benzimidazole]The American Journal of Tropical Medicine and Hygiene, 1964
- Clinical Trials with Thiabendazole against Human StrongyloidiasisThe American Journal of Tropical Medicine and Hygiene, 1963
- Creeping Eruption and Intestinal StrongyloidiasisBMJ, 1949